Follow
Joost Verbeek
Joost Verbeek
radiochemist, vu university medical center amsterdam
Verified email at quicknet.nl
Title
Cited by
Cited by
Year
Evaluation of [11C] laniquidar as a tracer of P-glycoprotein: radiosynthesis and biodistribution in rats
G Luurtsema, RC Schuit, RP Klok, J Verbeek, JE Leysen, ...
Nuclear medicine and biology 36 (6), 643-649, 2009
812009
[11C]phenytoin revisited: synthesis by [11C]CO carbonylation and first evaluation as a P-gp tracer in rats
J Verbeek, J Eriksson, S Syvänen, M Labots, ECM de Lange, RA Voskuyl, ...
EJNMMI research 2, 1-11, 2012
412012
Radiosynthesis and biodistribution of a histamine H3 receptor antagonist 4-[3-(4-piperidin-1-yl-but-1-ynyl)-[11C] benzyl]-morpholine: evaluation of a potential PET ligand
AJ Airaksinen, JA Jablonowski, M van der Mey, AJ Barbier, RP Klok, ...
Nuclear medicine and biology 33 (6), 801-810, 2006
402006
Design, Synthesis, Radiolabeling, and in Vitro and in Vivo Evaluation of Bridgehead Iodinated Analogues of N-{2-[4-(2-Methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl …
R Al Hussainy, J Verbeek, D van der Born, AH Braker, JE Leysen, RJ Knol, ...
Journal of medicinal chemistry 54 (10), 3480-3491, 2011
372011
[11C] quinidine and [11C] laniquidar PET imaging in a chronic rodent epilepsy model: impact of epilepsy and drug-responsiveness
S Syvänen, V Russmann, J Verbeek, J Eriksson, M Labots, C Zellinger, ...
Nuclear medicine and biology 40 (6), 764-775, 2013
312013
Carbon-11 labeled tracers for in vivo imaging of P-glycoprotein function: kinetics, advantages and disadvantages
G Luurtsema, J Verbeek, M Lubberink, A A Lammertsma, R Dierckx, ...
Current topics in medicinal chemistry 10 (17), 1820-1833, 2010
282010
Recent Progress in Metal Catalyzed Direct Carboxylation of Aryl Halides and Pseudo Halides Employing CO2: Opportunities for 11C Radiochemistry
M Ahamed, J Verbeek, U Funke, J Lecina, A Verbruggen, G Bormans
ChemCatChem 8 (24), 3692-3700, 2016
272016
Quantification of dynamic 11C-phenytoin PET studies
S Mansor, R Boellaard, FE Froklage, EDM Bakker, M Yaqub, RA Voskuyl, ...
Journal of Nuclear Medicine 56 (9), 1372-1377, 2015
262015
Design, synthesis and in vitro evaluation of bridgehead fluoromethyl analogs of N-{2-[4-(2-methoxyphenyl) piperazin-1-yl] ethyl}-N-(pyridin-2-yl) cyclohexanecarboxamide (WAY …
R Al Hussainy, J Verbeek, D van der Born, J Booij, JKDM Herscheid
European journal of medicinal chemistry 46 (12), 5728-5735, 2011
252011
Synthesis and preclinical evaluation of [11C] D617, a metabolite of (R)-[11C] verapamil
J Verbeek, S Syvänen, RC Schuit, J Eriksson, EC de Lange, ...
Nuclear medicine and biology 39 (4), 530-539, 2012
232012
Development and characterization of [123I] iodotiagabine for in-vivo GABA-transporter imaging
O Schijns, M van Kroonenburgh, F Beekman, J Verbeek, J Herscheid, ...
Nuclear Medicine Communications 34 (2), 175-179, 2013
122013
Molecular imaging of aurora kinase A (AURKA) expression: Synthesis and preclinical evaluation of radiolabeled alisertib (MLN8237)
JACM Goos, J Verbeek, AA Geldof, AC Hiemstra, MA van de Wiel, ...
Nuclear medicine and biology 43 (1), 63-72, 2016
112016
Synthesis, biodistribution and PET studies in rats of 18F-Labeled bridgehead fluoromethyl analogues of WAY-100635
R Al Hussainy, J Verbeek, D van der Born, C Molthoff, J Booij, ...
Nuclear medicine and biology 39 (7), 1068-1076, 2012
102012
Sharing and collecting hospital-based health technology assessment reports internationally: Is an extensive participation of stakeholders realistic?
J Verbeek, M Hiligsmann, A Cicchetti, M Marchetti
International Journal of Technology Assessment in Health Care 34 (5), 527-534, 2018
82018
The binding characteristics and orientation of a novel radioligand with distinct properties at 5-HT3A and 5-HT3AB receptors
AJ Thompson, MHP Verheij, J Verbeek, AD Windhorst, IJP de Esch, ...
Neuropharmacology 86, 378-388, 2014
82014
Synthesis and preliminary preclinical evaluation of fluorine-18 labelled isatin-4-(4-methoxyphenyl)-3-thiosemicarbazone ([18F]4FIMPTC) as a novel PET tracer of P …
J Verbeek, J Eriksson, S Syvänen, M Huisman, RC Schuit, CFM Molthoff, ...
EJNMMI radiopharmacy and chemistry 3, 1-19, 2018
52018
Initial evaluation of P2X (7) R antagonists [C-11] A-740003 and [C-11] SMW64-D16 as PET tracers of microglial activation in neuroinflammation
B Janssen, D Ory, SM Wilkinson, DJ Vugts, EJ Kooijman, J Verbeek, ...
Journal Of Labelled Compounds & Radiopharmaceuticals 58, S277-S277, 2015
52015
[C-11] Phenytoin is a weak P-glycoprotein substrate in rat-Initial PET studies
M Labots, J Verbeek, J Eriksson, EC de Lange, RC Schuit, M Rongen, ...
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS 54, S286-S286, 2011
32011
Binding characterization of N‐(2‐chloro‐5‐thiomethylphenyl)‐N′‐(3‐[3H] 3methoxy phenyl)‐N′‐methylguanidine ([3H] GMOM), a non‐competitive N‐methyl‐D‐aspartate (NMDA) receptor …
A Metaxas, BNM van Berckel, PJ Klein, J Verbeek, EC Nash, ...
Pharmacology Research & Perspectives 7 (1), e00458, 2019
22019
Parametric methods for dynamic 11C-phenytoin PET studies
S Mansor, M Yaqub, R Boellaard, FE Froklage, A De Vries, EDM Bakker, ...
Journal of Nuclear Medicine 58 (3), 479-483, 2017
22017
The system can't perform the operation now. Try again later.
Articles 1–20